The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global In-Vitro Colorectal Cancer Screening Tests Market Insights and Forecast to 2028

Global In-Vitro Colorectal Cancer Screening Tests Market Insights and Forecast to 2028

Publishing Date : Jan, 2022

License Type :
 

Report Code : 1658529

No of Pages : 113

Synopsis
In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.
Market Analysis and Insights: Global In-Vitro Colorectal Cancer Screening Tests Market
The global In-Vitro Colorectal Cancer Screening Tests market size is projected to reach US$ 1526.7 million by 2028, from US$ 1044.9 million in 2021, at a CAGR of 5.5% during 2022-2028.
The industry's leading producers are Alere(Abbott), Beckman Coulter and Siemens Healthcare, which accounted for 31.59%, 18.71% and 10.67% of revenue in 2019, respectively.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global In-Vitro Colorectal Cancer Screening Tests market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global In-Vitro Colorectal Cancer Screening Tests market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global In-Vitro Colorectal Cancer Screening Tests market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global In-Vitro Colorectal Cancer Screening Tests market.
Global In-Vitro Colorectal Cancer Screening Tests Scope and Market Size
In-Vitro Colorectal Cancer Screening Tests market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global In-Vitro Colorectal Cancer Screening Tests market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Biomarker Tests
Fecal Occult Blood Tests
CRC DNA Screening Tests
Segment by Application
Hospital and Clinics
Ambulatory
Home Care
By Company
Alere(Abbott)
Beckman Coulter
Siemens Healthcare
Eiken Chemical
Hitachi Chemical (Kyowa Medex)
Clinical Genomics Pty Ltd (Quest Diagnostics)
Sysmex
QIAGEN
R-Biopharm
Immunostics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Index
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Biomarker Tests
1.2.3 Fecal Occult Blood Tests
1.2.4 CRC DNA Screening Tests
1.3 Market by Application
1.3.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital and Clinics
1.3.3 Ambulatory
1.3.4 Home Care
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global In-Vitro Colorectal Cancer Screening Tests Market Perspective (2017-2028)
2.2 In-Vitro Colorectal Cancer Screening Tests Growth Trends by Region
2.2.1 In-Vitro Colorectal Cancer Screening Tests Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 In-Vitro Colorectal Cancer Screening Tests Historic Market Size by Region (2017-2022)
2.2.3 In-Vitro Colorectal Cancer Screening Tests Forecasted Market Size by Region (2023-2028)
2.3 In-Vitro Colorectal Cancer Screening Tests Market Dynamics
2.3.1 In-Vitro Colorectal Cancer Screening Tests Industry Trends
2.3.2 In-Vitro Colorectal Cancer Screening Tests Market Drivers
2.3.3 In-Vitro Colorectal Cancer Screening Tests Market Challenges
2.3.4 In-Vitro Colorectal Cancer Screening Tests Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-Vitro Colorectal Cancer Screening Tests Players by Revenue
3.1.1 Global Top In-Vitro Colorectal Cancer Screening Tests Players by Revenue (2017-2022)
3.1.2 Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Players (2017-2022)
3.2 Global In-Vitro Colorectal Cancer Screening Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In-Vitro Colorectal Cancer Screening Tests Revenue
3.4 Global In-Vitro Colorectal Cancer Screening Tests Market Concentration Ratio
3.4.1 Global In-Vitro Colorectal Cancer Screening Tests Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Colorectal Cancer Screening Tests Revenue in 2021
3.5 In-Vitro Colorectal Cancer Screening Tests Key Players Head office and Area Served
3.6 Key Players In-Vitro Colorectal Cancer Screening Tests Product Solution and Service
3.7 Date of Enter into In-Vitro Colorectal Cancer Screening Tests Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-Vitro Colorectal Cancer Screening Tests Breakdown Data by Type
4.1 Global In-Vitro Colorectal Cancer Screening Tests Historic Market Size by Type (2017-2022)
4.2 Global In-Vitro Colorectal Cancer Screening Tests Forecasted Market Size by Type (2023-2028)
5 In-Vitro Colorectal Cancer Screening Tests Breakdown Data by Application
5.1 Global In-Vitro Colorectal Cancer Screening Tests Historic Market Size by Application (2017-2022)
5.2 Global In-Vitro Colorectal Cancer Screening Tests Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America In-Vitro Colorectal Cancer Screening Tests Market Size (2017-2028)
6.2 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Type
6.2.1 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2017-2022)
6.2.2 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2023-2028)
6.2.3 North America In-Vitro Colorectal Cancer Screening Tests Market Share by Type (2017-2028)
6.3 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Application
6.3.1 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2017-2022)
6.3.2 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2023-2028)
6.3.3 North America In-Vitro Colorectal Cancer Screening Tests Market Share by Application (2017-2028)
6.4 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Country
6.4.1 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2017-2022)
6.4.2 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe In-Vitro Colorectal Cancer Screening Tests Market Size (2017-2028)
7.2 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Type
7.2.1 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2017-2022)
7.2.2 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2023-2028)
7.2.3 Europe In-Vitro Colorectal Cancer Screening Tests Market Share by Type (2017-2028)
7.3 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Application
7.3.1 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2017-2022)
7.3.2 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2023-2028)
7.3.3 Europe In-Vitro Colorectal Cancer Screening Tests Market Share by Application (2017-2028)
7.4 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Country
7.4.1 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2017-2022)
7.4.2 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size (2017-2028)
8.2 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Type
8.2.1 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2017-2022)
8.2.2 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2023-2028)
8.2.3 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Share by Type (2017-2028)
8.3 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Application
8.3.1 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2017-2022)
8.3.2 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2023-2028)
8.3.3 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Share by Application (2017-2028)
8.4 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Region
8.4.1 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Region (2017-2022)
8.4.2 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America In-Vitro Colorectal Cancer Screening Tests Market Size (2017-2028)
9.2 Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Type
9.2.1 Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2017-2022)
9.2.2 Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2023-2028)
9.2.3 Latin America In-Vitro Colorectal Cancer Screening Tests Market Share by Type (2017-2028)
9.3 Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Application
9.3.1 Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2017-2022)
9.3.2 Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2023-2028)
9.3.3 Latin America In-Vitro Colorectal Cancer Screening Tests Market Share by Application (2017-2028)
9.4 Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Country
9.4.1 Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2017-2022)
9.4.2 Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size (2017-2028)
10.2 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Type
10.2.1 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2017-2022)
10.2.2 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2023-2028)
10.2.3 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Share by Type (2017-2028)
10.3 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Application
10.3.1 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2017-2022)
10.3.2 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2023-2028)
10.3.3 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Share by Application (2017-2028)
10.4 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Country
10.4.1 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2017-2022)
10.4.2 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Alere(Abbott)
11.1.1 Alere(Abbott) Company Details
11.1.2 Alere(Abbott) Business Overview
11.1.3 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Introduction
11.1.4 Alere(Abbott) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
11.1.5 Alere(Abbott) Recent Developments
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Details
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Introduction
11.2.4 Beckman Coulter Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
11.2.5 Beckman Coulter Recent Developments
11.3 Siemens Healthcare
11.3.1 Siemens Healthcare Company Details
11.3.2 Siemens Healthcare Business Overview
11.3.3 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Introduction
11.3.4 Siemens Healthcare Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
11.3.5 Siemens Healthcare Recent Developments
11.4 Eiken Chemical
11.4.1 Eiken Chemical Company Details
11.4.2 Eiken Chemical Business Overview
11.4.3 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Introduction
11.4.4 Eiken Chemical Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
11.4.5 Eiken Chemical Recent Developments
11.5 Hitachi Chemical (Kyowa Medex)
11.5.1 Hitachi Chemical (Kyowa Medex) Company Details
11.5.2 Hitachi Chemical (Kyowa Medex) Business Overview
11.5.3 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Introduction
11.5.4 Hitachi Chemical (Kyowa Medex) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
11.5.5 Hitachi Chemical (Kyowa Medex) Recent Developments
11.6 Clinical Genomics Pty Ltd (Quest Diagnostics)
11.6.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Company Details
11.6.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview
11.6.3 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Introduction
11.6.4 Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
11.6.5 Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Developments
11.7 Sysmex
11.7.1 Sysmex Company Details
11.7.2 Sysmex Business Overview
11.7.3 Sysmex In-Vitro Colorectal Cancer Screening Tests Introduction
11.7.4 Sysmex Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
11.7.5 Sysmex Recent Developments
11.8 QIAGEN
11.8.1 QIAGEN Company Details
11.8.2 QIAGEN Business Overview
11.8.3 QIAGEN In-Vitro Colorectal Cancer Screening Tests Introduction
11.8.4 QIAGEN Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
11.8.5 QIAGEN Recent Developments
11.9 R-Biopharm
11.9.1 R-Biopharm Company Details
11.9.2 R-Biopharm Business Overview
11.9.3 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Introduction
11.9.4 R-Biopharm Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
11.9.5 R-Biopharm Recent Developments
11.10 Immunostics
11.10.1 Immunostics Company Details
11.10.2 Immunostics Business Overview
11.10.3 Immunostics In-Vitro Colorectal Cancer Screening Tests Introduction
11.10.4 Immunostics Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
11.10.5 Immunostics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
List of Tables
Table 1. Global In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Biomarker Tests
Table 3. Key Players of Fecal Occult Blood Tests
Table 4. Key Players of CRC DNA Screening Tests
Table 5. Global In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global In-Vitro Colorectal Cancer Screening Tests Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global In-Vitro Colorectal Cancer Screening Tests Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Region (2017-2022)
Table 9. Global In-Vitro Colorectal Cancer Screening Tests Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Region (2023-2028)
Table 11. In-Vitro Colorectal Cancer Screening Tests Market Trends
Table 12. In-Vitro Colorectal Cancer Screening Tests Market Drivers
Table 13. In-Vitro Colorectal Cancer Screening Tests Market Challenges
Table 14. In-Vitro Colorectal Cancer Screening Tests Market Restraints
Table 15. Global In-Vitro Colorectal Cancer Screening Tests Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global In-Vitro Colorectal Cancer Screening Tests Revenue Share by Players (2017-2022)
Table 17. Global Top In-Vitro Colorectal Cancer Screening Tests by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Colorectal Cancer Screening Tests as of 2021)
Table 18. Ranking of Global Top In-Vitro Colorectal Cancer Screening Tests Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by In-Vitro Colorectal Cancer Screening Tests Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players In-Vitro Colorectal Cancer Screening Tests Product Solution and Service
Table 22. Date of Enter into In-Vitro Colorectal Cancer Screening Tests Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Type (2017-2022)
Table 26. Global In-Vitro Colorectal Cancer Screening Tests Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Type (2023-2028)
Table 28. Global In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global In-Vitro Colorectal Cancer Screening Tests Revenue Share by Application (2017-2022)
Table 30. Global In-Vitro Colorectal Cancer Screening Tests Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global In-Vitro Colorectal Cancer Screening Tests Revenue Share by Application (2023-2028)
Table 32. North America In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2023-2028) & (US$ Million)
Table 62. Alere(Abbott) Company Details
Table 63. Alere(Abbott) Business Overview
Table 64. Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Product
Table 65. Alere(Abbott) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022) & (US$ Million)
Table 66. Alere(Abbott) Recent Developments
Table 67. Beckman Coulter Company Details
Table 68. Beckman Coulter Business Overview
Table 69. Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Product
Table 70. Beckman Coulter Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022) & (US$ Million)
Table 71. Beckman Coulter Recent Developments
Table 72. Siemens Healthcare Company Details
Table 73. Siemens Healthcare Business Overview
Table 74. Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Product
Table 75. Siemens Healthcare Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022) & (US$ Million)
Table 76. Siemens Healthcare Recent Developments
Table 77. Eiken Chemical Company Details
Table 78. Eiken Chemical Business Overview
Table 79. Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Product
Table 80. Eiken Chemical Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022) & (US$ Million)
Table 81. Eiken Chemical Recent Developments
Table 82. Hitachi Chemical (Kyowa Medex) Company Details
Table 83. Hitachi Chemical (Kyowa Medex) Business Overview
Table 84. Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Product
Table 85. Hitachi Chemical (Kyowa Medex) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022) & (US$ Million)
Table 86. Hitachi Chemical (Kyowa Medex) Recent Developments
Table 87. Clinical Genomics Pty Ltd (Quest Diagnostics) Company Details
Table 88. Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview
Table 89. Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Product
Table 90. Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022) & (US$ Million)
Table 91. Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Developments
Table 92. Sysmex Company Details
Table 93. Sysmex Business Overview
Table 94. Sysmex In-Vitro Colorectal Cancer Screening Tests Product
Table 95. Sysmex Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022) & (US$ Million)
Table 96. Sysmex Recent Developments
Table 97. QIAGEN Company Details
Table 98. QIAGEN Business Overview
Table 99. QIAGEN In-Vitro Colorectal Cancer Screening Tests Product
Table 100. QIAGEN Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022) & (US$ Million)
Table 101. QIAGEN Recent Developments
Table 102. R-Biopharm Company Details
Table 103. R-Biopharm Business Overview
Table 104. R-Biopharm In-Vitro Colorectal Cancer Screening Tests Product
Table 105. R-Biopharm Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022) & (US$ Million)
Table 106. R-Biopharm Recent Developments
Table 107. Immunostics Company Details
Table 108. Immunostics Business Overview
Table 109. Immunostics In-Vitro Colorectal Cancer Screening Tests Product
Table 110. Immunostics Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022) & (US$ Million)
Table 111. Immunostics Recent Developments
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Type: 2021 VS 2028
Figure 2. Biomarker Tests Features
Figure 3. Fecal Occult Blood Tests Features
Figure 4. CRC DNA Screening Tests Features
Figure 5. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Application: 2021 VS 2028
Figure 6. Hospital and Clinics Case Studies
Figure 7. Ambulatory Case Studies
Figure 8. Home Care Case Studies
Figure 9. In-Vitro Colorectal Cancer Screening Tests Report Years Considered
Figure 10. Global In-Vitro Colorectal Cancer Screening Tests Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global In-Vitro Colorectal Cancer Screening Tests Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Region: 2021 VS 2028
Figure 13. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Players in 2021
Figure 14. Global Top In-Vitro Colorectal Cancer Screening Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Colorectal Cancer Screening Tests as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by In-Vitro Colorectal Cancer Screening Tests Revenue in 2021
Figure 16. North America In-Vitro Colorectal Cancer Screening Tests Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America In-Vitro Colorectal Cancer Screening Tests Market Size Market Share by Type (2017-2028)
Figure 18. North America In-Vitro Colorectal Cancer Screening Tests Market Size Market Share by Application (2017-2028)
Figure 19. North America In-Vitro Colorectal Cancer Screening Tests Market Size Share by Country (2017-2028)
Figure 20. United States In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe In-Vitro Colorectal Cancer Screening Tests Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe In-Vitro Colorectal Cancer Screening Tests Market Size Market Share by Type (2017-2028)
Figure 24. Europe In-Vitro Colorectal Cancer Screening Tests Market Size Market Share by Application (2017-2028)
Figure 25. Europe In-Vitro Colorectal Cancer Screening Tests Market Size Share by Country (2017-2028)
Figure 26. Germany In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific In-Vitro Colorectal Cancer Screening Tests Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific In-Vitro Colorectal Cancer Screening Tests Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific In-Vitro Colorectal Cancer Screening Tests Market Size Share by Region (2017-2028)
Figure 36. China In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size Market Share by Type (2017-2028)
Figure 44. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size Market Share by Application (2017-2028)
Figure 45. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size Share by Country (2017-2028)
Figure 46. Mexico In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size Share by Country (2017-2028)
Figure 52. Turkey In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Alere(Abbott) Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
Figure 56. Beckman Coulter Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
Figure 57. Siemens Healthcare Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
Figure 58. Eiken Chemical Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
Figure 59. Hitachi Chemical (Kyowa Medex) Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
Figure 60. Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
Figure 61. Sysmex Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
Figure 62. QIAGEN Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
Figure 63. R-Biopharm Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
Figure 64. Immunostics Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’